MNPR
USDMonopar Therapeutics Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$85.950
最高
$86.140
最低
$80.105
交易量
0.14M
公司基本面
市值
510.3M
行業
生物科技
國家
United States
交易統計
平均交易量
0.07M
交易所
NCM
貨幣
USD
52週範圍
相關新聞
Barclays Initiates Coverage On Monopar Therapeutics with Overweight Rating, Announces Price Target of $125
Barclays analyst Etzer Darout initiates coverage on Monopar Therapeutics with a Overweight rating and announces Price Target of $125.
Raymond James Maintains Strong Buy on Monopar Therapeutics, Raises Price Target to $142
Raymond James analyst Chris Raymond maintains Monopar Therapeutics with a Strong Buy and raises the price target from $80 to $142.
HC Wainwright & Co. Maintains Buy on Monopar Therapeutics, Raises Price Target to $105
HC Wainwright & Co. analyst Andres Y. Maldonado maintains Monopar Therapeutics with a Buy and raises the price target from $70 to $105.
Piper Sandler Maintains Overweight on Monopar Therapeutics, Raises Price Target to $95
Piper Sandler analyst Biren Amin maintains Monopar Therapeutics with a Overweight and raises the price target from $76 to $95.
Chardan Capital Maintains Buy on Monopar Therapeutics, Raises Price Target to $85
Chardan Capital analyst Keay Nakae maintains Monopar Therapeutics with a Buy and raises the price target from $60 to $85.
BTIG Maintains Buy on Monopar Therapeutics, Raises Price Target to $104
BTIG analyst Jeet Mukherjee maintains Monopar Therapeutics with a Buy and raises the price target from $87 to $104.
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (NASDAQ:MNPR) ("Monopar Therapeutics", "Monopar", or the "Company"), a clinical-stage biopharmaceutical company developing innovative
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。